CSF2 and neoplasm: To test this, GL261-mice were treated with i. c. injections of ZIKV as well as subcutaneous vaccination (comprised of 5x106 IR GL261 cells previously infected with ZIKV and 20ng of the dendritic cell adjuvant GM-CSF) on days 3, 7, and 14 post-tumor induction.